Form 4: Xencor CFO Bart Jan Cornelissen Reports Stock Sale to Cover Tax Obligations
SEC Form 4 Filing
Xencor's CFO, Bart Jan Cornelissen, sold 3,750 shares of common stock on April 10, 2025, to cover withholding taxes related to the vesting of restricted stock units.
Summary
- On April 10, 2025, Bart Jan Cornelissen, the Senior Vice President & CFO of Xencor Inc. (XNCR), sold 3,750 shares of common stock.
- The sale was executed at a price of $8.0621 per share.
- This transaction was conducted to cover withholding taxes associated with the vesting of 14,088 restricted stock units.
- Following the transaction, Cornelissen directly owns 61,348 shares of Xencor common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock sale for tax purposes. It doesn't inherently indicate positive or negative sentiment regarding the company's performance.
Industry Context
Form 4 filings are a routine part of the regulatory landscape, providing transparency into the transactions of company insiders. This particular filing reflects a common practice of selling shares to cover tax obligations related to equity compensation.
Stakeholder Impact
- The sale of shares by a company executive could be perceived neutrally or slightly negatively by shareholders, depending on their individual investment strategies and interpretations of insider transactions.
Key Dates
| Date | Description |
|---|---|
| 04/10/2025 | Date of stock sale transaction. |
| 04/14/2025 | Date of signature on the Form 4 filing. |
Keywords
Xencor, Cornelissen, Stock Sale, Form 4, Insider Trading, Restricted Stock Units, Tax Withholding, XNCR
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.